Suppr超能文献

基于不同基因和生物标志物表达的肾脏疾病诊断与治疗的先进方法。

Advanced Approaches Based on Expression of Different Genes and Biomarkers for the Diagnosis and Treatment of Renal Disorders.

作者信息

Sharma Monika, Pandey Varsha, Sharma Chandra Kant

机构信息

Department of Bioscience and Biotechnology, Banasthali Vidyapith (Women's University), Rajasthan, India.

Institute of Agricultural Science, SAGE University, Indore, India-452020.

出版信息

Crit Rev Eukaryot Gene Expr. 2019;29(4):319-332. doi: 10.1615/CritRevEukaryotGeneExpr.2019025864.

Abstract

This review focuses on the causes and complications of chronic kidney disease (CKD). The kidneys are major organs boasting various natural functions, chief among them the stable equilibrium of body fluids by eliminating waste. If the symptoms of CKD can be detected early, effective care is possible. CKD is a major area of investigation because it is the ninth most common cause of death in the United States. The incidence of kidney infection can be correlated with kidney malfunction. The main serological markers for renal disease are serum creatinine and creatinine clearance, which are insensitive and nonspecific to recognition of kidney injury. Standard therapy to prevent the progression of CKD includes dietary protein restriction, hypertension control, angiotensin converting enzyme inhibition (ACEi), and angiotensin receptor barricade (ARB). In this review we discuss advances in research on diagnostic biomarkers related to renal diseases and kidney-related injuries.

摘要

本综述聚焦于慢性肾脏病(CKD)的病因及并发症。肾脏是具有多种自然功能的主要器官,其中最主要的功能是通过排出废物来维持体液的稳定平衡。如果能早期发现CKD的症状,就有可能进行有效的治疗。CKD是一个主要的研究领域,因为它是美国第九大常见死因。肾脏感染的发生率与肾功能障碍相关。肾脏疾病的主要血清学标志物是血清肌酐和肌酐清除率,它们对识别肾损伤不敏感且不具特异性。预防CKD进展的标准疗法包括饮食蛋白质限制、控制高血压、血管紧张素转换酶抑制(ACEi)和血管紧张素受体阻断(ARB)。在本综述中,我们讨论了与肾脏疾病和肾脏相关损伤相关的诊断生物标志物的研究进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验